National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting, 69091 [2010-28374]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 217 / Wednesday, November 10, 2010 / Notices
Contact Person: Philippe Marmillot, PhD,
Scientific Review Officer, National Institutes
of Health, National Institute on Alcohol
Abuse and Alcoholism, 5635 Fishers Lane,
Room 2019, Bethesda, MD 20892, 301–443–
2861, marmillotp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: November 3, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
emcdonald on DSK2BSOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Clinical Treatment and
Health Services Research Review
Subcommittee.
Date: March 15–16, 2011.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Katrina Foster, PhD,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room
2019, Rockville, MD 20852, 301–443–4032,
katrinaf@mail.nih.gov.
18:25 Nov 09, 2010
Jkt 223001
[FR Doc. 2010–28374 Filed 11–9–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Director, Office of
Biotechnology Activities; Notice of
Meeting
BILLING CODE 4140–01–P
VerDate Mar<15>2010
Dated: November 3, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2010–28376 Filed 11–9–10; 8:45 am]
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
There will be a workshop entitled
‘‘Retroviral and Lentiviral Vectors for
Long-Term Gene Correction: Clinical
Challenges in Vector and Trial Design.’’
The meeting will be open to the public;
attendance is limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Recombinant DNA
Advisory Committee.
Date: December 9, 2010.
Time: 8 a.m. to 5:30 p.m.
Date: December 10, 2010.
Time: 8 a.m. to 1 p.m.
Agenda: The Office of Biotechnology
Activities (OBA), NIH Recombinant DNA
Advisory Committee and the European
Network for the Advancement of Clinical
Gene Transfer (CliniGene) will host a
workshop on Retroviral and Lentiviral
Vectors for Long-Term Gene Correction:
Clinical Challenges in Vector and Trial
Design at the Bethesda Marriott on December
9 and 10, 2010. The meeting will cover the
following topics: Developments in retrovirus
and lentivirus integration and insertional
mutagenesis research, including nonenhancer mediated mechanisms of
insertional mutagenesis; modifications to
retroviral and lentiviral vectors to enhance
their safety; research on in vitro and animal
models to evaluate the safety of human gene
transfer; and ethical issues in the design of
new clinical trials. The agenda is posted to
OBA’s Web site: https://oba.od.nih.gov/
rdna_rac/rac_meetings.html. Please check
the meeting agenda for more information.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, Maryland 20814.
Contact Person: Chezelle George, Program
Assistant, Office of Science Policy, Office of
Biotechnology Activities, National Institutes
of Health, 6705 Rockledge Drive, Suite 750,
Bethesda, MD 20892, 301–496–9838, 301–
496–9839, georgec@mail.nih.gov.
Any interested person may file written
comments with the panel by forwarding the
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
69091
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
Background information may be obtained by
contacting NIH OBA by e-mail
oba@od.nih.gov
Dated: November 1, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology
Activities, National Institutes of Health.
[FR Doc. 2010–28373 Filed 11–9–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Interagency Autism Coordinating
Committee (IACC) Subcommittee on
Safety.
The Interagency Autism Coordinating
Committee (IACC) Subcommittee on
Safety will be meeting on Monday,
November 29, 2010. The subcommittee
plans to discuss issues related to autism
and safety. This meeting will be open to
the public and will be accessible
through a conference call.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of Meeting: Subcommittee on Safety.
Date: November 29, 2010.
Time: 9 a.m. to 12 p.m. Eastern Time.
Agenda: To discuss issues related to
autism and safety.
Place: The Neuroscience Center, 6001
Executive Boulevard, Conference Room B1/
B2, Rockville, MD 20852.
Conference Call Access: Dial: 800–369–
1754. Access code: 5105457.
Cost: The meeting is free and open to the
public.
Registration: https://
www.acclaroresearch.com/oarc/11–29–10/.
Pre-registration is recommended to expedite
check-in. Seating in the meeting room is
limited to room capacity and on a first come,
first served basis.
Access: Metro accessible—White Flint
Metro (Red Line).
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, NSC, Room 8185a,
Rockville, MD 20852. Phone: 301–443–6040.
E-mail: IACCPublicInquiries@mail.nih.gov.
Please Note:
The meeting will be open to the public and
accessible through a conference call.
Members of the public who participate using
the conference call phone number will be
E:\FR\FM\10NON1.SGM
10NON1
]]>Agencies
[Federal Register Volume 75, Number 217 (Wednesday, November 10, 2010)]
[Notices]
[Page 69091]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28374]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
USC, as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group; Clinical Treatment and Health
Services Research Review Subcommittee.
Date: March 15-16, 2011.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Katrina Foster, PhD, Scientific Review Officer,
National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room 2019, Rockville, MD
20852, 301-443-4032, katrinaf@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research and Research Support Awards, National Institutes of Health,
HHS)
Dated: November 3, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-28374 Filed 11-9-10; 8:45 am]
BILLING CODE 4140-01-P
